|
|
||||||||
Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298
CD23, also known as the low affinity IgE receptor (Fc
RII), has
been hypothesized to have a role in IgE regulation. A new CD23
transgenic mouse was generated using the MHC class I promoter and IgH
enhancer to further test the hypothesis that CD23 plays a role in the
down-regulation of IgE. Study of three founder lines by FACS showed
overexpression to varying extents on both B and T lymphocytes. No
alterations in lymphocyte populations was observed. All three founder
lines exhibited strong suppression of IgE in response to DNP-keyhole
limpet hemocyanin/alum and Nippostrongylus brasiliensis
infection compared with that in parental or littermate controls. The
founder line exhibiting the highest level of suppression also was less
susceptible to Ag-induced systemic anaphylactic shock. Overall, the
data support the concept that enhancing CD23 levels can be used to
suppress IgE-mediated disease. The mechanism involves decreased IgE
synthesis, because the serum half-life of IgE was not altered in
transgenics, and enzyme-linked immunospot analysis demonstrated lower
IgE-producing cells stimulated by injection of anti-IgD.
Transgenics also exhibited significantly decreased IgG1 responses and
exhibited lower levels of all Ig isotypes, although this was more
variable in different founder lines.
This article has been cited by other articles:
![]() |
G. Pongratz, J. W. McAlees, D. H. Conrad, R. S. Erbe, K. M. Haas, and V. M. Sanders The Level of IgE Produced by a B Cell Is Regulated by Norepinephrine in a p38 MAPK- and CD23-Dependent Manner. J. Immunol., September 1, 2006; 177(5): 2926 - 2938. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Gounni The high-affinity IgE receptor (Fc{epsilon}RI): a critical regulator of airway smooth muscle cells? Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L312 - L321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sukumar, D. H. Conrad, A. K. Szakal, and J. G. Tew Differential T Cell-Mediated Regulation of CD23 (Fc{epsilon}RII) in B Cells and Follicular Dendritic Cells. J. Immunol., April 15, 2006; 176(8): 4811 - 4817. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Getahun, F. Hjelm, and B. Heyman IgE Enhances Antibody and T Cell Responses In Vivo via CD23+ B Cells J. Immunol., August 1, 2005; 175(3): 1473 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montagnac, A. Molla-Herman, J. Bouchet, L. C. H. Yu, D. H. Conrad, M. H. Perdue, and A. Benmerah Intracellular Trafficking of CD23: Differential Regulation in Humans and Mice by Both Extracellular and Intracellular Exons J. Immunol., May 1, 2005; 174(9): 5562 - 5572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kilmon, A. E. Shelburne, Y. Chan-Li, K. L. Holmes, and D. H. Conrad CD23 Trimers Are Preassociated on the Cell Surface Even in the Absence of Its Ligand, IgE J. Immunol., January 15, 2004; 172(2): 1065 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rabah, S. Grant, C. Ma, and D. H. Conrad Bryostatin-1 Specifically Inhibits In Vitro IgE Synthesis J. Immunol., November 1, 2001; 167(9): 4910 - 4918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kilmon, R. Ghirlando, M.-P. Strub, R. L. Beavil, H. J. Gould, and D. H. Conrad Regulation of IgE Production Requires Oligomerization of CD23 J. Immunol., September 15, 2001; 167(6): 3139 - 3145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Payet-Jamroz, S. L. T. Helm, J. Wu, M. Kilmon, M. Fakher, A. Basalp, J. G. Tew, A. K. Szakal, N. Noben-Trauth, and D. H. Conrad Suppression of IgE Responses in CD23-Transgenic Animals Is Due to Expression of CD23 on Nonlymphoid Cells J. Immunol., April 15, 2001; 166(8): 4863 - 4869. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sancho, A. G. Santis, J. L. Alonso-Lebrero, F. Viedma, R. Tejedor, and F. Sanchez-Madrid Functional Analysis of Ligand-Binding and Signal Transduction Domains of CD69 and CD23 C-Type Lectin Leukocyte Receptors J. Immunol., October 1, 2000; 165(7): 3868 - 3875. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |